Reviva Pharmaceuticals
RVPH
RVPH
42 hedge funds and large institutions have $14M invested in Reviva Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6% less capital invested
Capital invested by funds: $14.9M → $14M (-$927K)
13.46% less ownership
Funds ownership: 30.06% → 16.6% (-13%)
Holders
42
Holding in Top 10
–
Calls
$2.79M
Puts
$1.65M
Top Buyers
| 1 | +$650K | |
| 2 | +$308K | |
| 3 | +$251K | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$84.1K |
| 5 |
EGM
Engineers Gate Manager
New York
|
+$62.6K |
Top Sellers
| 1 | -$3.3M | |
| 2 | -$986K | |
| 3 | -$829K | |
| 4 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$223K |
| 5 |
Focus Partners Wealth
Boston,
Massachusetts
|
-$183K |